Financial statements Agagamed
Company suspended its operations from 2025-08-20
Balance sheet data of AGAGAMED
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 4 809,00 | 194 567,88 | 303 402,47 | 279 590,13 | 293 684,12 |
| A. Fixed assets | 0,00 | 10 080,00 | 104 192,89 | 75 758,53 | 50 684,12 |
| B. Current assets | 4 809,00 | 184 487,88 | 199 209,58 | 203 831,60 | 243 000,00 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 4 809,00 | 194 567,88 | 303 402,47 | 279 590,13 | 293 684,12 |
| A. Equity | 4 809,00 | 5 034,79 | -25 168,73 | -72 662,35 | -115 914,87 |
| B. Liabilities and provisions for liabilities | 0,00 | 189 533,09 | 328 571,20 | 352 252,48 | 409 598,99 |
| I. Long-term liabilities | - | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | - | 189 533,09 | 321 877,00 | 348 835,00 | 407 546,81 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.